APA

Gold D. P., Smith R. A., Golding A. B., Morgan E. E., Dafashy T., Nelson J., Smith L., Diveley J., Laxer J. A., Richieri S. P., Carlo D. J., Brostoff S. W. & Wilson D. B. (19970703). Results of a phase I clinical trial of a T-cell receptor vaccine in patients with multiple sclerosis. II. Comparative analysis of TCR utilization in CSF T-cell populations before and after vaccination with a TCRV beta 6 CDR2 peptide. : Journal of neuroimmunology.

Chicago

Gold D P, Smith R A, Golding A B, Morgan E E, Dafashy T, Nelson J, Smith L, Diveley J, Laxer J A, Richieri S P, Carlo D J, Brostoff S W and Wilson D B. 19970703. Results of a phase I clinical trial of a T-cell receptor vaccine in patients with multiple sclerosis. II. Comparative analysis of TCR utilization in CSF T-cell populations before and after vaccination with a TCRV beta 6 CDR2 peptide. : Journal of neuroimmunology.

Harvard

Gold D. P., Smith R. A., Golding A. B., Morgan E. E., Dafashy T., Nelson J., Smith L., Diveley J., Laxer J. A., Richieri S. P., Carlo D. J., Brostoff S. W. and Wilson D. B. (19970703). Results of a phase I clinical trial of a T-cell receptor vaccine in patients with multiple sclerosis. II. Comparative analysis of TCR utilization in CSF T-cell populations before and after vaccination with a TCRV beta 6 CDR2 peptide. : Journal of neuroimmunology.

MLA

Gold D P, Smith R A, Golding A B, Morgan E E, Dafashy T, Nelson J, Smith L, Diveley J, Laxer J A, Richieri S P, Carlo D J, Brostoff S W and Wilson D B. Results of a phase I clinical trial of a T-cell receptor vaccine in patients with multiple sclerosis. II. Comparative analysis of TCR utilization in CSF T-cell populations before and after vaccination with a TCRV beta 6 CDR2 peptide. : Journal of neuroimmunology. 19970703.